AR052399A1 - Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos - Google Patents

Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos

Info

Publication number
AR052399A1
AR052399A1 ARP050101645A ARP050101645A AR052399A1 AR 052399 A1 AR052399 A1 AR 052399A1 AR P050101645 A ARP050101645 A AR P050101645A AR P050101645 A ARP050101645 A AR P050101645A AR 052399 A1 AR052399 A1 AR 052399A1
Authority
AR
Argentina
Prior art keywords
alkyl chain
chain length
composition
branched alkyl
head group
Prior art date
Application number
ARP050101645A
Other languages
English (en)
Inventor
Michael James Lynch
Rudyard Istvan
Bart Chernow
Manzer Durrani
Robert Ya-Lin Pan
Abel Saud
Rosa Laura Moese
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR052399A1 publication Critical patent/AR052399A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones antimicrobianas terapéuticas y métodos para proporcionar eficacia antiviral y antibacteriana inmediata y residual mejorada contra hinovirus, rotavirus, coronovirus, virus respiratorio sincitial, bacterias gram positivas, bacterias gram negativas y combinaciones de éstos y métodos terapéuticos para el uso de las aquellas. Las composiciones antimicrobianas terapéuticas que comprenden un ácido orgánico o mezcla de ácido orgánico y un tensoactivo anionico de cadena corta que tiene por lo menos uno de un grupo cabeza grande y una cadena alquílica ramificada. Reivindicacion 1: Un método para tratar o prevenir una infeccion causada por microbios en un paciento que lo necesita; el método se caracteriza por comprender el paso de administrar una cantidad eficaz de una composicion anti-microbiana que comprende: a) entre 0,2% y 70% de un ácido orgánico; y b) entre 0,1% y 40% de una mezcla de tensoactivo anionico que tiene (i) una longitud de cadena alquílica lineal de entre C4 y C12 y un tamano total de grupo cabeza de por lo menos 4 Angstroms; y/o (ii) una longitud de cadena alquílica ramificada de entre C4 y C12; y/o (iii) una longitud de cadena alquílica ramificada de entre C4 y C12 y un tamano total de grupo cabeza de por lo menos 4 Angstroms; en donde dicha composicion se caracteriza por tener un pH de entre 2,0 y 4,5. Reivindicacion 13: Un método para prevenir las infecciones que se originan en dispositivo médicos en un paciente que lo necesita; el método se caracteriza por comprender la desinfeccion de los dispositivos con una cantidad eficaz de una composicion anti-microbiana que comprende: a) Entre 0,2% y 70% de un ácido orgánico; y b) entre 0,1% y 40% de una mezcla de tensoactivo anionico que tiene i. A una longitud de cadena alquílica lineal de entre C4 y C12 y un tamano total de grupo cabeza de por lo menos 4 Angstroms; y/o ii) Una longitud de cadena alquílica ramificada de entre C4 y C12; y/o iii) Una longitud de cadena alquílica ramificada de entre C4 y C12 y un tamano total de grupo cabeza de o lo menos 4 Angstroms; en donde la composicion se caracteriza por tener un pH de entre 2,0 y 4,5.
ARP050101645A 2004-04-26 2005-04-26 Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos AR052399A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56531104P 2004-04-26 2004-04-26

Publications (1)

Publication Number Publication Date
AR052399A1 true AR052399A1 (es) 2007-03-21

Family

ID=35149038

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101645A AR052399A1 (es) 2004-04-26 2005-04-26 Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos

Country Status (15)

Country Link
US (1) US20050271711A1 (es)
EP (2) EP1740166B1 (es)
JP (1) JP2007534701A (es)
CN (1) CN1946428A (es)
AR (1) AR052399A1 (es)
AT (1) ATE492272T1 (es)
AU (1) AU2005237546B2 (es)
BR (1) BRPI0510327A (es)
CA (2) CA2686815A1 (es)
DE (1) DE602005025466D1 (es)
ES (1) ES2360803T3 (es)
IL (1) IL178894A0 (es)
MX (1) MXPA06012442A (es)
NO (1) NO20065457L (es)
WO (1) WO2005105070A2 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050260243A1 (en) * 2004-04-26 2005-11-24 The Procter & Gamble Company Method of treating microbial plant diseases
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
MX2007006864A (es) * 2004-12-09 2008-02-15 Dial Corp Composiciones que tienen una alta eficacia antiviral y antibacteriana.
US20080267904A1 (en) * 2004-12-09 2008-10-30 The Dial Corporation Compositions Having A High Antiviral And Antibacterial Efficacy
MX2007006863A (es) * 2004-12-09 2008-02-25 Dial Corp Composiciones que tienen alta eficacia antiviral y antibacterial.
US9629361B2 (en) 2006-02-09 2017-04-25 Gojo Industries, Inc. Composition and method for pre-surgical skin disinfection
US8119115B2 (en) 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
MX2008014905A (es) * 2006-05-24 2009-03-05 Dial Corp Composicion y metodo para controlar la transmision de norovirus.
US20070274926A1 (en) * 2006-05-26 2007-11-29 The Dial Corporation Method of inhibiting the transmission of viruses
MX2008015188A (es) * 2006-05-30 2009-03-06 Dial Corp Composiciones que tienen una alta eficiencia antiviral.
WO2007142967A2 (en) * 2006-05-31 2007-12-13 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
CN101500418B (zh) 2006-06-02 2014-04-16 日晷公司 抑制流感病毒传播的方法
RU2008152442A (ru) * 2006-06-05 2010-07-20 Дзей Дайл Корпорейшн (Us) Способы и изделия, имеющие высокую противовирусную и противобактериальную эффективность
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US20090035339A1 (en) * 2006-10-10 2009-02-05 Rudyard Istvan Methods of Inactivating Viruses
RU2465891C2 (ru) * 2007-05-04 2012-11-10 Дзе Проктер Энд Гэмбл Компани Антибактериальные композиции, продукты и способы их применения
US20090062391A1 (en) * 2007-08-27 2009-03-05 Kent Christopher New Use of a virucidal ointment in the nares for prevention of transmission and contraction of common colds
US20090136430A1 (en) * 2007-11-27 2009-05-28 Dugger Harry A Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
GB0800788D0 (en) * 2008-01-16 2008-02-27 Glaxo Group Ltd Niovel formulation
JP5126745B2 (ja) * 2008-07-22 2013-01-23 国立大学法人鳥取大学 抗ウイルス剤及び抗ウイルス性シート
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
US8968243B2 (en) 2009-10-15 2015-03-03 Entratympanic, Llc Device and method for delivering medicine into the tympanic cavity,with sliding assist
US9744125B2 (en) * 2010-01-15 2017-08-29 Nuance Health, Llc Use of a virucidal preparation on an area of the face for prevention of transmission or contraction of viral illnesses, or to shorten the duration of, or lessen the severity of viral illnesses
CA2841832C (en) 2011-07-12 2019-06-04 Pursuit Vascular, Inc. Device for delivery of antimicrobial agent into a trans-dermal catheter
US8841640B1 (en) 2013-03-13 2014-09-23 Inceptus Technologies, Llc Apparatus for infection control
FR3019714B1 (fr) * 2014-04-10 2017-07-07 Salveco Nouveaux produits biocides
JP6546988B2 (ja) 2014-05-02 2019-07-17 エクセルシオール・メディカル・コーポレイションＥｘｃｅｌｓｉｏｒ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 防腐キャップのためのストリップパッケージ
JP6822978B2 (ja) 2015-05-08 2021-01-27 アイシーユー・メディカル・インコーポレーテッド 治療薬のエミッタを受け入れるように構成された医療用コネクタ
FR3045382B1 (fr) * 2015-12-17 2020-02-07 Tereos Starch & Sweeteners Belgium Composition antibacterienne contenant un monoether ou un monoacetal d'alkyle de desoxyhexose
WO2018071717A1 (en) 2016-10-14 2018-04-19 Icu Medical, Inc. Sanitizing caps for medical connectors
JP6951421B2 (ja) * 2017-03-28 2021-10-20 ロンザ・ソリューションズ・アー・ゲー 水溶性抗菌組成物
WO2018204206A2 (en) * 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
EP3687293A1 (en) 2017-09-26 2020-08-05 Ecolab Usa Inc. Acidic/anionic antimicrobial and virucidal compositions and uses thereof
KR101968028B1 (ko) 2017-12-26 2019-04-10 롯데첨단소재(주) 열가소성 수지 조성물 및 이로부터 제조된 성형품
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
EP3883638A1 (en) 2018-11-21 2021-09-29 ICU Medical, Inc. Antimicrobial device comprising a cap with ring and insert
CN111467338B (zh) * 2020-04-07 2021-04-23 中国科学院深圳先进技术研究院 焦谷氨酸在制备预防和治疗抗新冠肺炎新型冠状病毒的药物中的应用
WO2022125474A1 (en) 2020-12-07 2022-06-16 Icu Medical, Inc. Peritoneal dialysis caps, systems and methods

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1407997A (en) * 1972-08-01 1975-10-01 Procter & Gamble Controlled sudsing detergent compositions
US4136045A (en) * 1976-10-12 1979-01-23 The Procter & Gamble Company Detergent compositions containing ethoxylated nonionic surfactants and silicone containing suds suppressing agents
US4828912A (en) * 1981-07-20 1989-05-09 Kimberly-Clark Corporation Virucidal product having virucidal and/or germicidal properties
DE3229097A1 (de) * 1982-08-04 1984-02-09 Schülke & Mayr GmbH, 2000 Hamburg Mikrobizide mittel
US5006529A (en) * 1988-05-27 1991-04-09 Lever Brothers Company Soap compositions of enhanced antimicrobial effectiveness
DE4140473C2 (de) * 1991-12-09 1995-12-21 Schuelke & Mayr Gmbh Hautantiseptikum und Händedesinfektionsmittel
AU671208B2 (en) * 1993-06-30 1996-08-15 Colgate-Palmolive Company, The Anti-bacterial cleansing composition
US5681802A (en) * 1994-06-01 1997-10-28 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness
US5653970A (en) * 1994-12-08 1997-08-05 Lever Brothers Company, Division Of Conopco, Inc. Personal product compositions comprising heteroatom containing alkyl aldonamide compounds
US6110445A (en) * 1995-06-26 2000-08-29 Colgate-Palmotive Company Oral composition exhibiting improved uptake and retention of antibacterial compounds on dental tissue surfaces
GB2309706B (en) * 1996-01-31 2000-02-09 Reckitt & Colman Inc Liquid detergent composition comprising quaternary ammonium surfactant having germicidal properties
US6190675B1 (en) * 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6190674B1 (en) * 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6488943B1 (en) * 1999-04-13 2002-12-03 The Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
TR200201048T2 (tr) * 1999-10-19 2002-08-21 The Procter & Gamble Company Soğuk algınlığı ve gribi andıran semptomların önlenmesi ve tedavisi için bileşimler
CA2394612A1 (en) * 2000-01-20 2001-07-26 The Procter & Gamble Company Antimicrobial compositions
ATE346901T1 (de) * 2000-06-05 2006-12-15 Johnson & Son Inc S C Biozide reinigungsmittel
US20020192407A1 (en) * 2001-03-01 2002-12-19 The Procter & Gamble Company Pre-moistened wipe with improved feel and softness
FR2822377A1 (fr) * 2001-03-23 2002-09-27 Oreal Utilisation de fibres comme agent anti-irritant dans une composition cosmetique ou dermatologique
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US7067227B2 (en) 2002-05-23 2006-06-27 Applied Materials, Inc. Sensitized chemically amplified photoresist for use in photomask fabrication and semiconductor processing
EP1515607A2 (en) * 2002-06-21 2005-03-23 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
US20040001797A1 (en) * 2002-06-21 2004-01-01 Abel Saud Antimicrobial compositions, products and methods employing same
US20050260243A1 (en) * 2004-04-26 2005-11-24 The Procter & Gamble Company Method of treating microbial plant diseases

Also Published As

Publication number Publication date
EP1740166A2 (en) 2007-01-10
CA2562329C (en) 2009-12-22
BRPI0510327A (pt) 2007-10-23
AU2005237546A1 (en) 2005-11-10
ATE492272T1 (de) 2011-01-15
CA2562329A1 (en) 2005-11-10
CA2686815A1 (en) 2005-11-10
EP1740166B1 (en) 2010-12-22
MXPA06012442A (es) 2007-01-17
JP2007534701A (ja) 2007-11-29
CN1946428A (zh) 2007-04-11
DE602005025466D1 (de) 2011-02-03
EP2298351A2 (en) 2011-03-23
US20050271711A1 (en) 2005-12-08
ES2360803T3 (es) 2011-06-09
WO2005105070A3 (en) 2006-03-16
AU2005237546B2 (en) 2009-09-10
EP2298351A3 (en) 2012-06-06
NO20065457L (no) 2006-11-27
WO2005105070A2 (en) 2005-11-10
IL178894A0 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
AR052399A1 (es) Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos
Atiyeh et al. Wound cleansing, topical antiseptics and wound healing
AR040447A1 (es) Composicion antimicrobiana y producto antimicrobiano que lo comprende y metodos de eliminar bacterias, inactivar virus, proveer eficacia antibacteriana residual, prevenir y/o tratar un resfriado comun, enfermedad respiratoria y diarrea en un mamifero, prevenir y/o tratar enfermedades relacionadas a
AR052398A1 (es) Metodos para tratar o prevenir una infeccion microbiana en una planta y para desinfectar implementos agricolas
CO2018008829A2 (es) Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
RU2011137204A (ru) Антисептические композиции и их применения
GB2480772A (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus
BR0313670A (pt) Composição ácida para limpeza pesada de superfìcies
ATE489082T1 (de) Pharmazeutische zusammenstellungen zur behandlung von hautzuständen
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
MX2007005678A (es) Azucares y alcoholes de azucar para inhibir y/o tratar la infeccion vaginal.
BRPI1012219C1 (pt) produto, substrato, composição farmacêutica, usos de um produto, e de um peptídeo antimicrobiano, métodos para prevenir formação de biofilme em um ambiente, para tratar uma infecção microbiana por profilaxia ou terapia, e para tratar ou prevenir formação de biofilme em um ambiente, e, uso de uma cisteamina
ATE528311T1 (de) Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
MX2007006861A (es) Composiciones que tienen alta eficacia antiviral y antibacterial.
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
AR075274A1 (es) Agente de tratamiento de semillas y metodo para proteger una planta
CO7230346A2 (es) Uso de agente quelante y compuestos antimicrobianos de pétido
AR081973A1 (es) Composiciones y metodos para incrementar la reduccion de microorganismos formadores de esporas
AR029544A1 (es) Composiciones y metodos para tratar infecciones bacterianas
AR066372A1 (es) Formulaciones de aminoacidos n-halogenados con compuestos antiinflamatorios
CL2008001279A1 (es) Metodo para mejorar la actividad antimicrobiana de una formulacion que comprende un aminoacido n-halogenado que comprende un agente de transferencia de fase; formulacion; metodo para desinfectar superficies y lentes de contacto; metodo para tratar una infeccion de tejido y para tratar infecciones respiratorias.
MX2007006864A (es) Composiciones que tienen una alta eficacia antiviral y antibacteriana.
NZ630347A (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
AR045070A1 (es) Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico

Legal Events

Date Code Title Description
FB Suspension of granting procedure